SHAWNA CHOYCE: Open Payments
NPI 1811366842 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$554 in 23 payments from 6 companies in 2025. Trend: 2023 $700 · 2024 $932 · 2025 $554
Food & beverage: $361Education: $193
| Company | Payments | Amount |
|---|---|---|
| OPKO Pharmaceuticals, LLC | 13 | $210 |
| Mallinckrodt Hospital Products Inc. | 2 | $207 |
| Travere Therapeutics, Inc. | 5 | $59 |
| Otsuka America Pharmaceutical, Inc. | 1 | $30 |
| Alexion Pharmaceuticals, Inc. | 1 | $27 |
| Calliditas Therapeutics US Inc. | 1 | $21 |
Products named: RAYALDEE, ACTHAR, VOYXACT, ULTOMIRIS, TARPEYO.
Industry payments across LA — which companies pay providers there.
